Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

BACKGROUND: There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). METHODS: We assessed the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:N Engl J Med
Autori principali: Reynolds, Harmony R., Adhikari, Samrachana, Pulgarin, Claudia, Troxel, Andrea B., Iturrate, Eduardo, Johnson, Stephen B., Hausvater, Anaïs, Newman, Jonathan D., Berger, Jeffrey S., Bangalore, Sripal, Katz, Stuart D., Fishman, Glenn I., Kunichoff, Dennis, Chen, Yu, Ogedegbe, Gbenga, Hochman, Judith S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Massachusetts Medical Society 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206932/
https://ncbi.nlm.nih.gov/pubmed/32356628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2008975
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi